Maagdenberg, Hedy <br/><br/>
Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients.  [electronic resource] 

 -  Pharmacogenomics  10 2018 
 - 1195-1202 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-8042 
<br/><br/><label>Standard No.: </label>10.2217/pgs-2018-0095  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age Factors<br/>Anticoagulants--administration & dosage<br/>Child<br/>Child, Preschool<br/>Cytochrome P-450 CYP2C9--genetics<br/>Cytochrome P-450 CYP3A--genetics<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Humans<br/>Infant<br/>Male<br/>Pharmacogenetics--methods<br/>Phenprocoumon--administration & dosage<br/>Polymorphism, Single Nucleotide--genetics<br/>Retrospective Studies<br/>Vitamin K Epoxide Reductases--genetics